bioRxivMicrobiology
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
K. R. McCarthy, L. J. Rennick, S. Nambulli, L. R. Robinson-McCarthy, W. G. Bain, G. Haidar, W. P. Duprex
Abstract
Zoonotic pandemics, like that caused by SARS-CoV-2, can follow the spillover of animal viruses into highly susceptible human populations. Their descendants have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses, due to a proofreading polymerase. In the spike glycoprotein, we find recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS-CoV-2 antigenic evolution and may, more generally, drive adaptive evolution.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased frequency of recurrent in-frame deletions in new expanding lineages of SARS CoV-2 reflects immune selective pressure
A. Alisoltani, L. Jaroszewski, … A. Godzik·bioRxiv·Jul 4, 2021
- Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein
Marco Gerdol, Klevia Dishnica, Alejandro Giorgetti·Virus ResearchPeer-reviewed·Jan 10, 2022
- Deletion disrupts a conserved antibody epitope in a SARS-CoV-2 variant of concern
L. L. Rennick, L. R. Robinson-McCarthy, … K. R. McCarthy·bioRxiv·Mar 5, 2021
- Evolutionary dynamics of indels in SARS-CoV-2 spike glycoprotein
R. Shyama Prasad Rao, Nagib Ahsan, … Dong He Xu·Evolutionary BioinformaticsPeer-reviewed·Jan 1, 2021
- The SARS-CoV-2 spike receptor-binding domain has evolved decreased inherent antigenicity in humans
Catherine Jacob-Dolan, Jim B. Boonyaratanakornkit, Jesse D. Bloom·bioRxiv·Oct 16, 2026
- Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
Xiaodi Yu, Jarek Juraszek, … Johannes P. M. Langedijk·PLoS PathogensPeer-reviewed·May 1, 2023